These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 1855903)

  • 1. Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure.
    Fischer S; Spiegelhalder B; Preussmann R
    IARC Sci Publ; 1991; (105):489-92. PubMed ID: 1855903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco-specific nitrosamines in European and USA cigarettes.
    Fischer S; Spiegelhalder B; Preussmann R
    Arch Geschwulstforsch; 1990; 60(3):169-77. PubMed ID: 2369279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco-specific nitrosamines in Canadian cigarettes.
    Fischer S; Castonguay A; Kaiserman M; Spiegelhalder B; Preussmann R
    J Cancer Res Clin Oncol; 1990; 116(6):563-8. PubMed ID: 2254375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes.
    Fischer S; Spiegelhalder B; Eisenbarth J; Preussmann R
    Carcinogenesis; 1990 May; 11(5):723-30. PubMed ID: 2335004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco-specific nitrosamines in mainstream smoke of West German cigarettes--tar alone is not a sufficient index for the carcinogenic potential of cigarette smoke.
    Fischer S; Spiegelhalder B; Preussmann R
    Carcinogenesis; 1989 Jan; 10(1):169-73. PubMed ID: 2910520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of major carcinogenic tobacco-specific N-nitrosamines in Thai cigarettes.
    Brunnemann KD; Mitacek EJ; Liu Y; Limsila T; Suttajit M
    Cancer Detect Prev; 1996; 20(2):114-21. PubMed ID: 8706036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preformed tobacco-specific nitrosamines in tobacco--role of nitrate and influence of tobacco type.
    Fischer S; Spiegelhalder B; Preussmann R
    Carcinogenesis; 1989 Aug; 10(8):1511-7. PubMed ID: 2752525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and analysis of tobacco-specific N-nitrosamines.
    Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
    Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing cigarette, 1950-1995.
    Hoffmann D; Hoffmann I
    J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoke yields of tobacco-specific nitrosamines in relation to FTC tar level and cigarette manufacturer: analysis of the Massachusetts Benchmark Study.
    Harris JE
    Public Health Rep; 2001; 116(4):336-43. PubMed ID: 12037262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco-specific N-nitrosamines in tobacco and mainstream smoke of Indian cigarettes.
    Kumar R; Siddiqi M; Tricker AR; Preussmann R
    Food Chem Toxicol; 1991 Jun; 29(6):405-7. PubMed ID: 1874469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco-Specific Nitrosamines in the Tobacco and Mainstream Smoke of U.S. Commercial Cigarettes.
    Edwards SH; Rossiter LM; Taylor KM; Holman MR; Zhang L; Ding YS; Watson CH
    Chem Res Toxicol; 2017 Feb; 30(2):540-551. PubMed ID: 28001416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
    Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
    J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking.
    Adams JD; Lee SJ; Vinchkoski N; Castonguay A; Hoffmann D
    Cancer Lett; 1983 Jan; 17(3):339-46. PubMed ID: 6831390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in the tobacco specific nitrosamine (TSNA) content of tobaccos taken from commercial Canadian cigarettes and corresponding reductions in TSNA deliveries in mainstream smoke from such cigarettes.
    Rickert WS; Joza PJ; Sharifi M; Wu J; Lauterbach JH
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):306-10. PubMed ID: 18508168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of major carcinogens and alkaloids in the tobacco and mainstream smoke of USSR cigarettes.
    Djordjevic MV; Sigountos CW; Hoffmann D; Brunnemann KD; Kagan MR; Bush LP; Safaev RD; Belitsky GA; Zaridze D
    Int J Cancer; 1991 Feb; 47(3):348-51. PubMed ID: 1993541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
    Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
    Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke--a contribution to relative risk evaluation.
    Fischer S; Spiegelhalder B; Preussmann R
    Carcinogenesis; 1989 Jun; 10(6):1059-66. PubMed ID: 2720900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco-specific N-nitrosamines NNN and NNK levels in cigarette brands between 2000 and 2014.
    Gunduz I; Kondylis A; Jaccard G; Renaud JM; Hofer R; Ruffieux L; Gadani F
    Regul Toxicol Pharmacol; 2016 Apr; 76():113-20. PubMed ID: 26806560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties.
    Ding YS; Zhang L; Jain RB; Jain N; Wang RY; Ashley DL; Watson CH
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3366-71. PubMed ID: 19064552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.